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Abstract
Heart disease is the major leading cause of death worldwide and the use of stem cells promises new ways for its treatment. The
relatively easy and quick acquisition of human umbilical cord matrix mesenchymal stem cells (HUMSCs) and their properties
make them useful for the treatment of cardiac diseases. Therefore, the main aim of this investigation was to create cardiac
polymicrotissue from HUMSCs using a combination of growth factors [sphingosine-1-phosphate (S1P) and suramin] and
techniques (hanging drop and bioreactor). Using designated culture conditions of the growth factors (100 nMS1P and 500mM
suramin), cardiomyocyte differentiation medium (CDM), hanging drop, bioreactor and differentiation for 7 days, a potential
speciﬁc cardiac polymicrotissue was derived from HUMSCs. The effectiveness of growth factors alone or in combination in
differentiation of HUMSCs to cardiac polymicrotissue was analysed by assessing the presence of cardiac markers by
immunocytochemistry. This analysis demonstrated the importance of those growth factors for the differentiation. This study
for the ﬁrst time demonstrated the formation of a cardiac polymicrotissue under speciﬁc culture conditions. The
polymicrotissue thus obtained may be used in future as a ‘patch’ to cover the injured cardiac region and would thereby be
useful for the treatment of heart diseases.
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Introduction
Cardiac disease, a disorder that affects heart, is a major cause of
deathworldwide (MensahandBrown, 2007). It has beenproved
that replacement of injured heart cells by healthy cardiac cells
through mitotic division has limited activity (Karabekian et al.,
2011). To overcome this obstacle, three types of stem cells
[Pluripotent stem cells (PSCs), MSCs and induced PSCs
(iPSCs)]havebeenused (WilliamsandHare, 2011;Mazhari and
Hare, 2012; Yamanaka, 2012). However, iPSCs may not have
clinical applications in the near future because their differentia-
tion is achieved through re-programming. This obstacle
conﬁrmed the necessity of using MSCs, which is one step
forward of differentiation from PSCs use, for replacing injured
heart cells.Nevertheless, their ability to differentiate into cardiac
cells is a complex biologic process and poorly understood,
where twomajor signaling pathways are involved. They are the
Wnt canonical pathway and transforming growth factor-b
(TGF-b) superfamily pathway (Augello and De Bari, 2010).
Sphingosine-1-phosphate (S1P) and suramin are poten-
tial growth factors for the differentiation of human umbilical
cordMSCs (HUMSCs) andmouse embryonic stem cells into
cardiomyocytes, respectively (Wiese et al., 2011; Zhao et al.,
2011). S1P sphingolipid has potent effects on the embryonic
and neural stem cell differentiation, proliferation and
maintenance (Avery et al., 2008; Price et al., 2009). Suramin,
a derivative of urea, exerts many effects on various cell
functions including proliferation, migration and differenti-
ation (Wiese et al., 2011).
The primary aim of this study was the in vitro
differentiation of HUMSCs towards cardiomyocytes render-
ing that as a new way for the treatment of heart diseases. To
achieve that, different concentrations of S1P and suramin
have been used separately on monolayer cells (2D) and in
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combination for creating polymicrotissues (3D) with car-
diomyocyte characteristics. At the same time, the proper
differentiation and maturation stage of the cardiac single
polymicrotissue has been characterized by assessing the
expression of a speciﬁc cardiac marker. The main advantage
of 3Dover 2Dcell culture is that itmaintains the in-vivo tissue
characteristics. In this study the ‘hanging drop’ microtissue
procedure was used that may lead to an alternative and more
effective result than the artiﬁcial tissue used in the past (Kelm
et al., 2005). Providing the proper microenviromental culture
conditions and reﬁning the procedure, the creation of
polymicrotissue with potential speciﬁc cardiomyogenic
characteristics, from HUMSCs, was succeeded. Polymicro-
tissue thus obtained could be used to replace the injured part
of the heart. In addition to the growth factors, the othermajor
factors contributing to the formation of polymicrotissue,
whichconsists of 20,000 cells ormore,were the ‘hangingdrop’
technique, where a single monomicrotissue consisting of
approximately 1000 cells was formed, and a bioreactor, where
monomicrotissue converted into polymicrotissue.
Materials and methods
Cell culture conditions
HUMSCs derived from the human umbilical cords that were
obtained fromhealthdonors at SingletonHospital, Swanseawith
informed consent and approval by South West Wales Research
Ethics Committee. HUMSCs were cultured in DMEM-F12
(Invitrogen) basal medium or Cardiomyocyte Differentiation
Medium (CDM, Millipore) containing 10% fetal bovine serum
(FBS, Biosera), 100units/mL penicillin and 0.1mg/mL strepto-
mycin. The cells were maintained in a humidiﬁed incubator at
37C and 5% CO2 and passaged when the cellular conﬂuence
was over 80%.
Differentiation of HUMSCs to cardiac cells in amonolayer
form
To differentiate HUMSCs to cardiac cells, HUMSCs were
subcultured in 96-well plates and treated individually with
DMEM-F12 medium containing three different concen-
trations of S1P (0.1mM, 0.5mM and 1mM) or suramin
(0.1mM, 0.2mM and 0.5mM) for 7 days. Cardiac differen-
tiation was assessed morphologically using phase-contrast
microscope and immunocytochemically by staining the cells
with speciﬁc cardiac marker antibodies.
Preparation and live/dead cell staining of individual
microtissues
HUMSCs were seeded at the density of 1000 cells in 20mL
DMEM-F12 medium per well into 60-well Terasaki plates
(Greiner BioOne) and the plates were incubated upside
down in an incubator at 37C/5% CO2 for 24 h to form
microtissue in hanging drops. Then the medium with
microtissues was transferred into a 96-well-plate containing
80mL of medium in each well and subjected to live/dead cell
staining. The microtissues were washed twice with PBS and
stained for 30min at 37C with Live/Dead cell viability kit
[Invitrogen, ethidium homodimer-1 (2mL/mL in PBS) and
calcein-AM (0.5mL/mL in PBS)]. The tissue was then
washed twice with PBS and imaged by Carl-Zeiss LSM710
confocal microscope.
Differentiation of HUMSCs to cardiac polymicrotissue
One millilitre microtissue suspension (CDM plus 20 single
monomicrotissues) in a 1.5mLmicrofuge was rotated end to
end, using a bioreactor, at 37C and 5% CO2 to form a
polymicrotissue. Rotating forces application to microtissues
led them to form a polymicrotissue. The position of the
microfuge was horizontal on the bioreactor resulting in the
single monomicrotissues meeting at the same point forming
one single polymicrotissue. The treatment conditions were
CDM plus 100 nM S1P for 5 days and then CDM plus
100 nM S1P and 500mM suramin for 2–days. After the 7th
day, the polymicrotissue was maintained in CDM by
changing the medium every 3 days.
Immunocytochemistry
The monolayer of cells in 96-well plate were washed with PBS
and ﬁxed for 10min with 10% formalin. Next, the cells were
washed thrice with PBS and permeabilised with PBS plus 0.1%
Triton X-100. Afterwards, the cells were incubated with the
primary antibody [rabbit anti-hyperpolarization-activated
cyclic nucleotide-gated potassium channel (HCN)4, Alomone,
ormouse anti-cardiac troponin (cTn)T,Abcam]diluted 1:50 in
PBS at 4C overnight. The cellswere then washed three times
with PBS and incubated with the secondary antibody (FITC-
conjugated anti-rabbit IgG or FITC-conjugated anti-mouse
IgG or FITC-conjugated anti-rabbit IgG; Cy5-conjugated anti-
mouse IgG, and TRITC-conjugated phalloidin, which is to
stain the cytoskeleton) for 45min in the dark at room
temperature. The dilutions for the secondary antibodies and
phalloidinwere 1:200 and 1:5000 in PBS, respectively. The cells
were then washed three times with PBS, stained with DAPI
(stains the nucleus) at a dilution of 1:1000 in PBS and stored at
4C until the time for confocal microscope use. All images
presented are single optical sections and processed using
LSM710 Image Bowser (Zeiss Ltd).
The polymicrotissue was washed ﬁve times with PBS,
ﬁxed for 10min with 10% formalin and immunostained as
described above using anti-HCN4 and anti-rabbit Cy3-IgG
antibodies.
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Results
Immunocytochemical confirmation of 2D
cardiomyogenic differentiation
Firstly, the 2D cardiomyogenic differentiation of HUMSCs
in the presence of growth factors suramin or S1P was
assessed. For this purpose, HUMSCs were treated with
different concentrations of the growth factors, and the
differentiation was assessed by immunostaining for the
presence of cardiac markers HCN4 and cTnT. HUMSCs
treated with 0.2mM and 0.5mM suramin, and 0.1mM,
0.5mMand 1mMS1P showed immunostaining with an anti-
HCN4 antibody (Figure 1). Similarly, HUMSCs incubated
with 0.5mM suramin and 0.5mM S1P showed immuno-
staining with an anti-cTnT antibody. However, untreated
HUMSCs grown for 7 days in the absence of growth factors
not only maintained the MSCs morphology but also showed
no immunostaining with either the anti-HCN4 or an anti-
cTnT antibodies (data not shown).
Immunohistochemical confirmation of 3D
cardiomyogenic differentiation
We next determined the therapeutic potentiality of
cardiomyogenic differentiation of HUMSCs by generating
3D spheroid microtissues of cardiac cell types from
HUMSCs. The viability of the single monomicrotissue was
assessed using live/dead cell staining (Figure 2A) where the
percentage of dead cells corresponds to physiological
experimental level of cell mortality.
Next, we differentiated HUMSCs into poly-microcardio-
myotissues using a bioreactor (for culturing cells) and a
combination of S1P (100 nM) and suramin (500mM). The
differentiation at different time points of incubation with the
growth factors was assessed immunocytochemically using
HCN4 antibody (Figure 2). According to Figure 1, 100nM
S1P and 500mM suramin are optimal to trigger the
differentiation of HUMSCs towards cardiomyocytes. We,
therefore, used 100nM S1P for 7 days and 500mM suramin
for 48 h from the 5th day to generate 3D spheroid micro-
tissues. CDMwas chosen as a feeding factor for 3D culture to
provide the proper microenvironmental conditions.
HUMSCs differentiation to potential cardiac polymicrotis-
sues was assessed by immunostaining (Figure 2). Polymicro-
tissue was also immunostained without HCN4 antibody
(Figure 2B) to assess the background staining. Figures 2C and
D correspond to immunostaining with HCN4 antibody of
polymicrotissue under untreated and treated conditions
respectively, which both showed the same level of HCN4
expression.
Furthermore, ﬁbrogenesis has already taken place con-
sisted of a syncytium of asymmetrically elongated mononu-
clear ﬁbres. The latter fused and formed an elongated
multinucleatedﬁbre visible in Figures 2B–E. Figures 2DandE
correspond to the improper developmental maturation time
points due to the improper location of the ﬁbres. Figure 2F
shows that the differentiation and proper maturation time
point was 15 days (7 days with the growth factors and 8 days
without them) whereby the mononuclear cardiac ﬁbres have
already moved to reside in their ﬁnal position in a vertical
manner to cardiomyocytes. Supporting Information movies
S1 and S2 show the rotated movement in 3D of the
polymicrotissue and the potential cardiac polymicrotissue,
respectively, from Figures 2E and F.
Discussion
The easy and quick acquisition of HUMSCs from placenta
and the fact that iPSCsdonot have clinical applications, so far,
and also the embryonic stem cells is one step of differentiation
behind of HUMSCs, render them a major tool for the
treatment of many diseases (Anzalone et al., 2010). However,
HUMSCs differentiation into cardiomyocytes is less studied
so far. In this study,we report the transformationofHUMSCs
into cardiac cell types. In particular, we demonstrated, by
immunostaining with speciﬁc antibodies, the expression of
HCN4 and cTnT cardiac myocyte markers in HUMSCs
differentiated using growth factors suramin and S1P. We
Figure 1 Immunostaining ofHCN4 or cTnT inHUMSCs treatedwith
suramin or S1P. HUMSCs treated with indicating concentrations of
either suramin for 2 days (from5th day plating) or S1P for 7 days, ﬁxed and
immunostained using an anti-HCN4 or anti-cTnT. Blue colour corre-
sponds to DAPI staining (which stains the nucleus), red colour
corresponds to phalloidin staining (which stains the cytoskeleton) and
green colour corresponds to HCN4 or cTnT antibody staining.
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further demonstrated the successful differentiation and
maturation of HUMSCs into a single cardiac polymicrotissue
by using hanging drop/bioreactor, for providing the suitable
microenvironmental space, and a combination of the growth
factors S1P and suramin. The expression of HCN4 protein
and the residence of the mononuclear ﬁbres in the
differentiated tissue (Figure 2F), suggest, together, the proper
differentiation and maturation stage. Two differentiation
time points, over 7 days, were presented and themost proper,
according to this study, was 7 (polymicrotissue treated with
the growth factors) plus 8 (untreated conditions) days
(Movies S1 and S2).
Themolecular mechanism of the combined growth factors
action is poorly understood; nevertheless, an assumption
could be possible. The twomajor signaling pathways involved
in this differentiation process are the Wnt and TGF-b
superfamily pathway (Augello and De Bari, 2010). The
growth factors, S1P and suramin, act through these two
pathways. S1P binds to G-protein coupled receptors
(GPCRs), mainly the sphingosine-1-phosphate receptor 1
(S1PR1), that constitute the main receptors of Wnt pathway.
The ligand binding of GPCRs is connected with G-protein
activity, which is an important signal transduction pathway in
cells (Overington et al., 2006; Rao and Kuhl, 2010). Our
unpublished results suggest that S1P regulates cell division at
higher concentration and promotes cell adhesion at lower
concentration. For this reason, the lowest concentration
(100 nM)was preferred so that S1P’s role was limited only for
triggering the differentiation of HUMSCs to cardiomyocytes
(Zhao et al., 2011).
Suramin causes the contraction of the myocyte and the
rapid release of Caþ2 from the sarcoplasmic reticulum via
the ryanodine receptor/calcium release channel (Fabiato,
1983; Wolner et al., 2005). In addition, suramin inhibits the
TGF-b signaling and thereby prevents HUMSCs differ-
entiaing into other cell types (Kloen et al., 1994). Suramin
has also been shown to reduce the aggregation of Chinese
hamster ovary cells (Zanghi et al., 2000). Although suramin
may affect monomicrotissues aggregation, S1P eliminates
that. This speciﬁes the signiﬁcance of the rotating forces
action, generated by the bioreactor, on the monomicrotis-
sues leading to the creation of a single polymicrotissue.
The roles of S1P on Wnt pathway and suramin on TGF-b
pathway, together with the use of CDM and hanging drop/
Figure 2 Live/dead cells staining of a singlemicrotissue and immunostaining of HCN4 in HUMSCs polymicrotissues. A single monomicrotissue
stained with EThD1 (orange) and calcein-AM (green). Green corresponds to live cells and orange corresponds to dead cells (A). HUMSCs grown in the
absence of S1P and suramin for 7 days were ﬁxed and immunostainedwithout (B) or with (C) an anti-HCN4 antibody. A single polymicrotissue derived by
growing HUMSCs for 7 (D) or 11 (E) or 15 (F) days in the presence of S1P (100nM) and suramin (500mM) for ﬁrst 7 days. This was ﬁxed and
immunostained using an anti-HCN4 antibody. Blue corresponds to DAPI staining (which stains the nucleus) and red corresponds to HCN4 antibody
staining.
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bioreactor, lead to differentiation and maturation of
HUMSCs into cardiomyocyte microtissues. Importantly,
these conditions also bypass proarrythmic and tumorigenic
effects of in vitro differentiation of HUMSCs, which are two
important factors that could affect the safe use of MSCs
(Fabiato, 1983). An argument could take place here that
HUMSCs differentiated towards neuron cells, because this
cell type also expresses HCN4 protein (Cho et al., 2009).
However, the use of the designated conditions, such as the
suitable growth factors and CDM, confers that the HUMSCs
differentiation and maturation were limited not only into
cardiomyocytes and cardiac ﬁbres but also to a potential
speciﬁc cell type of them which was the cardiac pacemaker
cells. In addition, another argument is that the cardiac
polymicrotissue could be the result of overgrowing cells;
however the use of the growth factors, inducing the
differentiation of HUMSCs, and the proper culture
conditions weakens that. This study is useful for generating
differentiated cardiomyocytes, which could be used for
functional assessment of electrophysiological activities. Our
immediate futureworkwill concentrate on further optimising
the polymicrotissue techniques and electrophysiologyof these
polymicrotissues to conﬁrm their cardiomyocyte phenotypes.
Conclusion
The limited clinical applications of iPSC and the low number
of studies on the differentiation of HUMSCs towards
cardiomyocytes renders the current investigation an impor-
tant tool for the future. In this study, we managed to create,
on a small scale, a microcardiac tissue that, in a large scale
form, could be used as a ‘patch’ to the injured cardiac region,
contributing, at the same time, to the regenerative medicine
ﬁeld as well.
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Movie S1. 3D rotating form of a prospective cardiac
polymicrotissue. The cardiac ﬁbers have not moved to reside
in their ﬁnal position resulting in formation of elongated
multinucleated ﬁbers. Blue colour corresponds to DAPI
staining (which stains the nucleus) and red colour
corresponds to HCN4 antibody staining.
Movie S2. 3D rotating form of the potential cardiac
polymicrotissue. The mononuclear ﬁbers, almost individu-
ally, have resided in a vertical manner to cardiomyocytes.
Blue colour corresponds to DAPI staining (which stains the
nucleus) and red colour corresponds to HCN4 antibody
staining.
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